Table 1 Patient characteristics
Characteristics | Values |
|---|---|
Number of patients (n) | 31 |
Number of AGMs (n) | 34 |
Gender | |
Male | 17 (54.8%) |
Female | 14 (45.2%) |
Age at SBRT (median, range) [years] | 66.1 (26.7–82.2) |
Primary entities | |
NSCLC | 13 (41.9%) |
Mamma Ca | 6 (19.4%) |
Melanoma | 4 (12.9%) |
Others | 8 (25.8%) |
Symptoms | |
Present | 2 (6.5%) |
Absent | 29 (93.5%) |
KPS | |
100% | 1 (3.2%) |
90% | 19 (61.3%) |
80% | 10 (32.3%) |
≤ 70% | 4 (12.9%) |
Location of AGMs | |
Left | 15 (48.4%) |
Right | 13 (41.9%) |
Bilateral | 3 (9.7%) |
Controlled primary | |
Yes | 25 (80.6%) |
No | 6 (19.4%) |
AGM diagnosis | |
Synchronous | 15 (48.4%) |
Metachronous | 19 (61.3%) |
Metastases in other sites | |
Yes | 25 (80.6%) |
No | 6 (19.4%) |
Systemic therapy within four weeks before/after SBRT | |
Yes | 19 (61.3%) |
No | 12 (38.7%) |
FU-time (median, range) [months] | 9.8 (0–120.5) |